期刊文献+

1H—MRS评价激素性骨质疏松模型兔:与病理对照 被引量:5

MR Spectroscopy in Evaluation of Glucocorticoid-Induced Osteoporosis in Rabbits:Comparison with Histopathology
原文传递
导出
摘要 目的采用3.0 T磁共振波谱(1H-MRS)动态评估糖皮质激素诱导的兔骨质疏松模型骨髓脂质变化规律。方法将20只(5个月)雌性新西兰大白兔随机分为对照组及肌肉注射甲泼尼龙琥珀酸钠组(MPS组),每组10只。分别于0、4、8、12周行L3~L4及股骨近端MRS扫描及骨密度测定,获取骨髓脂质分数(LF)。第8周及12周各处死实验兔10只行病理组织学检查。结果第4、12周时,MPS组LF较基线时分别增高35.9%和75.2%(P值均<0.001)。第4周始,组间LF有显著性差异,而组间骨密度至第8周时差异有统计学意义(P<0.05)。第8、12周MPS组骨髓脂肪细胞密度较对照组分别增高57.1%和35.4%,而骨髓脂肪细胞直径分别降低13.3%、增高22.7%,骨髓脂肪细胞面积分别增高30.8%和53.8%。结论 MRS可以动态评估骨髓脂质变化规律。糖皮质激素诱导的骨质疏松初期骨髓脂肪以小尺寸脂肪细胞为主,后期以大尺寸脂肪细胞为主。 Objective To evaluate the temporal changes of marrow lipids content and adipocytes in rabbit model of glu- cocorticoid induced osteoporosis (GIOP) using 3 Tesla proton MR spectroscopy ( 1 H-MRS). Methods Twenty 5 - month - old female rabbits were randomly divided into control group and methylprednisolone (MPS) group ( n = 10 in each group). Marrow lipids fraction (LF) and bone mineral density at left proximal femur and L3 -L4 vertebrae were measured by MR spectroscopy and dual energy X-ray absorptiometry at 0, 4, 8, and 12 weeks. Marrow adipocyte density (Ad. D) , adipocyte mean diameter ( Ad. MD) , and percentage area of adipocyte ( Ad. V/Ma. V ) were quantitatively evaluated by histopathology. Results LF in MPS group showed a dramatic increase over time. Compared with baseline, LF increased by 35.9% and 75.2% at 4th week and 12th week. In MPS group, LF increased was detected at 4th week, while signifi- cant bone loss was detected at 8th week compared with control group ( P 〈 0.05 ). In contrast to control group at 8th week and 12th week , Ad. D increased by 57.1% and 35.4% in MPS group respectively. A decrease ( - 13.3% ) at 8th week but a significant increase ( + 22.7% ) at 12th week were found in Ad. Ad. V/Ma. V in MPS group was much larger than those of control rabbits at 8th week and 12th week (P 〈 O. 05 ). Conclusion The GIOP development was characterized by a significant increase in the number of small size adipocytes at early stage and big size adipocytes at late stage. MRS ap- pears to be the most powerful tool to characterize the dynamical change process of the marrow fat.
出处 《临床放射学杂志》 CSCD 北大核心 2013年第8期1193-1197,共5页 Journal of Clinical Radiology
基金 国家自然科学基金资助项目(编号:81202809) 上海市教委基金资助项目(编号:2010JW53)
关键词 糖皮质激素 骨质疏松 骨密度 磁共振波谱成像 Glucocorticoid Osteoporosis Bone mineral density Magnetic resonance spectroscopy
  • 相关文献

参考文献14

  • 1Weinstein RS. Glucocorticoids, osteocytes, and skeletal fragility : the role of bone vascularity. Bone,2010,46:564.
  • 2Weinstein RS. Glucocorticoid-Induced Bone Disease. N Engl J Med, 2011,365:62.
  • 3李冠武,常时新,鲍虹,周蕾,田芳,方巍.骨髓脂肪含量对预测骨质疏松性椎体骨折风险的初步应用[J].实用放射学杂志,2012,28(1):74-77. 被引量:33
  • 4Wren TA, Chung SA, Dorey FJ, et al. Bone marrow fat is inversely related to cortical bone in young and old subjects. J Clin Endocrinol Metab ,2011,96:782.
  • 5Castaneda S, Calvo E, Largo R, et al. Characterization of a new ex- perimental model of osteoporosis in rabbits. J Bone Miner Metab, 2008,26:53.
  • 6Luppen CA, Blake CA, Ammirati KM, et al. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glu- cocorticoid-treated rabbits. J Bone Miner Ptes ,2002,17:301.
  • 7Cohen A, Dempster DW, Stein EM,et al. Increased Marrow Adiposity in Premenopausal Women with Idiopathic Osteoporosis. J Clin Endo- crinol Metab ,2012,97:2782.
  • 8李冠武,汤光宇,李伟,彭屹峰,赵文荣,刘勇.去势法联合皮质激素快速诱导兔骨质疏松模型[J].临床放射学杂志,2011,30(7):1055-1058. 被引量:6
  • 9Majumdar SR, Lix LM, Yogendran M, et al. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids ( 1998-2008 ). J Clin Endocrinol Metab, 2012,97 : 1236.
  • 10Feldstein AC, Elmer PJ, Nichols GA, et al. Practice patterns in pa- tients at risk for glucocorticoid-inducedosteoporosis. Osteoporos Int, 2005,16:2168.

二级参考文献26

  • 1方忠,杨琴,李锋,段军,敦先礼.去势法兔骨质疏松模型建立的探讨[J].中国骨质疏松杂志,2005,11(2):202-205. 被引量:17
  • 2赵玉华,葛雪琳,杨霞,魏玲,蔡桂英.去势大鼠5种骨转换生化指标的动态变化[J].中国病理生理杂志,2007,23(3):548-552. 被引量:12
  • 3盛志峰,廖二元,伍贤平,方玲娜,范慧洁,戴如春.去卵巢大鼠胫骨骨小梁的显微CT研究[J].中华骨科杂志,2007,27(6):460-464. 被引量:7
  • 4Reginster JY, Burlet N. Osteoporosis: a still inetasing prevalence. Bone,2006,38(2Suppl 1 ) :54.
  • 5Castaneda S, l,argo R, Cairo E, et al. Bone mineral measuremenis .f subchondral and trabecular bone in healthy and steol?orotie rabbits. Skeletal Radio1,2006,35:34.
  • 6Castaneda S, Calvo E, Largo R, et aL. Characterizalion oJ a ncw cxperimental model of osteoporosis in rabbits. J Bone Miner Mctab, 2008,26:53.
  • 7Egermann M, Goldhahn J,Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos lnt, 2005,16 (Suppl 2 ) :S129.
  • 8Grardel B, Sutter B, Flautre B, et al. Effcts nt glucocortieoids on skeletal growth in rabbits evaluated by dual-photon absorptiometvy, micrnscopic connectivity and vertebral compressive strength. Osteoporos lnt, 1994,4:204.
  • 9Bolotin IIH, Siev anen H. Inaccuracies inherent in dual-energy X ray absorptiometry in vivo bone mineral density ean seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility..I Bone Miner Res,2001,16:799.
  • 10Pogoda P, Priemel M, Rueger JM, et al. Bone remode t g: new aspects of a key process that controls skeletal maintenance and repair. Osteoporos Int,2005,16 : S18.

共引文献51

同被引文献43

  • 1Link TM. Osteoporosis imaging: state of the art and advanced ima- ging. Radiology, 2012,263 : 3.
  • 2Shen W, Chen J, Gantz M, et al. MRI-measured pelvic bone marrow adipose tissue is inversely related to DXA-measured bone mineral in younger and older adults. Eur J Clin Nutr,2012 ,66 :983.
  • 3Harslcf T,Wamberg L, Mller L, et al. Rosiglitazone decreases bone mass and bone marrow fat. J Clin Endocrinol Metab,2011,96:1541.
  • 4Yeung DK,Griffith JF, Antonio GE, et al. Osteoporosis is associated with incased marrow fat content and decreased marrow fat unsatur- ation: a proton MR spectroscopy study. J Magn Reson Imaging, 2005,22:279.
  • 5Patsch JM, Li X, Baum T, et al. Bone marrow fat composition as a no- vel imaging biomarker inpostmenopausal women with prevalent fragil- ity fractures. J Bone Miner Res,2013,1002.
  • 6Perilli E, Le V, Ma B, et al. Detecting early bone changes using in vivo micro-CT inovariectomized, zoledronic acid-treated, and sham- operated rats. Osteoporos lnt ,2010,21 : 1371.
  • 7Castaneda S, Calvo E, Largo R, et al. Characterization of a new ex- perimental model of osteopomsis in rabbits. J Bone Miner Metab, 2008,26:53.
  • 8Li GW,Tang GY,Liu Y,et aL MR spectroscopy and micro-CT in e- valuation of osteoporosis model in rabbits: comparison with histopa- thology. Eur Radio1,2012 ,22 :923.
  • 9Bredella MA, Ghomi RH, Thomas B J, et al. Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellnlar lipids in obese and normal-weight women. J Magn Reson Imaging,2010,32:388.
  • 10Syed FA, Oursler M J, Hefferanm TE, et al. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int ,2008,19 : 1323.

引证文献5

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部